Tobacco Use Disorder
Financial incentives added to free cessation aids can improve the rate of sustained abstinence among smokers.
AAFP and other signatories also call on FDA to apply the proposal to other combustible tobacco products.
Youth with asthma have considerably higher use of tobacco products than those without asthma.
From 2011 to 2017 there were decreases in current use of any tobacco products among high and middle school students.
Researchers emphasized the necessity of developing targeted interventions to address such health disparities among American Indian communities.
UK National Health Service Explores Justification for Rationing Elective Surgery in Smokers, ObesityJune 08, 2018
Recent measures in the United Kingdom have proposed restricting access to elective surgery for smokers and people with obesity.
CDC Report: Integrating Tobacco Cessation Interventions in Mental Health, Substance Abuse Treatment FacilitiesJune 05, 2018
Providing barrier-free access to proven cessation treatments is critical to reduce smoking-related disease and death in the United States.
Researchers proposed that future projects investigate the geographical and temporal trends in substance use and its disease burden.
There were no observable differences in the incidence of any cardiovascular events across the smoking cessation treatment groups.
Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence between 1980 and 2014. Mortality rates for drug use disorders increased both nationally and in each county over the same period.
The findings of these analyses suggest that, to an extent, this relationship might be generalized to cannabis users as a whole, not just those diagnosed with a cannabis use disorder.
The more chemicals in e-liquid, the more toxic it is likely to be.
E-cigarettes are associated with more harm than good on a population level.
Most adolescent users of tobacco products do not identify as users.
Researchers calculated age-standardized mortality rates on a county level in the United States between 1980 and 2014, specifically examining rates for self-harm, interpersonal violence, alcohol use, and drug use.
Despite the recognition that early daily tobacco use likely increases the risk for later psychosis, investigation of the effect of covariates such as substance use, existing psychotic features, or parental/family factors was lacking in the literature.
There has been much variability in the capacity for pharmacological treatments to help curb alcoholism, and the research community has remained interested in determining specific factors that may predict the efficacy of treatments such as naltrexone.
Varenicline may have a role in the treatment of alcohol use disorder in men who smoke cigarettes.
In the US today, about 20% of adults use any type of tobacco product.
Researchers identified a DNA variant—located in the DNMT3B gene—that increases likelihood of nicotine dependence. The variant is commonly found in people of European and African descent. The discovery could create possibilities into new research for nicotine addiction treatments.
Factors including economics, environment, and demographic and social factors might put rural residents at a higher risk of these preventable causes of death.
The US Food and Drug Administration has determined that varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Compared with men who never used tobacco, those who used snus but did not smoke had a 24% higher risk of death from prostate cancer.
Researchers find heavy users have lower bone density than cigarette smokers.
Cigarette smoking prevalence among persons with severe mental illness is approximately 3 times greater than the rate observed in the general population.
Maternal tobacco smoking during pregnancy has previously been linked with numerous long-term neurodevelopmental abnormalities and child behavioral problems.
Varenicline is approved by the FDA for use as a smoking cessation aid.
Researchers analyzed smoking behavior of 1 470 veterans who enrolled in the SmokefreeVET tobacco cessation program between 2013 and 2014.
At 12 months, researchers found a significant association between smoking reduction and suicidality.
Bipolar disorder (BD) is typically characterized by recurrent episodes of mania and depression, but the connection between BD and anxiety needs to be considered.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Belief That Abortion Harms Women's Mental Health Appears Misinformed
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Autonomic Function May Have Directional Effect on Depression
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Substance Abuse and Primary Psychosis: A Closer Look
- Influence of Psychostimulants on BMI and Height in Youth With ADHD
- Medication Adherence Predictors in Patients With Severe Psychiatric Disorders
- Incidence of Extrapyramidal Symptoms Higher With Certain Antidepressants
- Little Evidence Nicotine Preloading Helps Smokers Quit
- Acute Insomnia Found to Be Common Among Good Sleepers